骨髓间充质干细胞对异基因骨髓移植后GVHD和生存率的影响  

The Effect of Bone Marrow Mesenchymal Stem Cells on Graft Versus Host Disease and Survival Rate After Allogeneic Bone Marrow Transplantation

作　　者：胡文兵[1] 高清平[1] 陈友华[1] 敖绪斌[1] 陈伦华[1] 

机构地区：[1]武汉大学人民医院血液科,湖北武汉430060

出　　处：《中国医师杂志》2005年第2期219-221,共3页Journal of Chinese Physician

摘　　要：目的　观察骨髓间充质干细胞 (BMMSC)对急性淋巴细胞白血病 (ALL)小鼠异基因骨髓移植 (allo -BMT)后移植物抗宿主病 (GVHD)和生存率的影响。方法　建立ALL小鼠动物模型 ,对其进行allo -BMT的同时 ,静脉输注体外培养的供鼠BMMSC ,同时设立单纯allo -BMT对照组。流式细胞仪检测受鼠CD4+ 、CD8+ T细胞亚群的差异 ;观察受鼠发生GVHD一般反应及病理学变化 ;记录受鼠存活时间。结果　BMMSC减少受鼠CD4+ T细胞的同时增加CD8+ T细胞 ;推迟GVHD发生的时间 ;明显延长ALL小鼠allo -BMT后的生存时间 (P <0 0 5或P <0 0 1)。结论　BMMSC能抑制ALL小鼠allo -BMT后GVHD的发生 ,但同时具有一定程度的GVL作用。Objective To observe the effect of bone marrow mesenchymal stem cells (BMMSC) on graft versus host disease (GVHD) and survival rate after allogenic bone marrow transplantation (allo-BMT) in acute lymphocytic leukemia (ALL) mice. Methods In the experimental group, both bone marrow cells and BMMSC obtained from donor mice were transplanted into the recipient mice injected with leukemia cells five days ago, and in the control group, the mice was injected with bone marrow cells alone. The impact of BMMSC on the quantity of CD 4 + and CD 8 + T cells after allo-BMT was evaluated by flow cytometry. The general manifestation and pathological changes of GVHD were observed. The survival time of recipient mice was recorded. Results BMMSC could decrease the quantity of CD 4 + T cells, increase CD 8 + T cells number, delay GVHD, and obviously increase the survival time in the mice treated with allo-BMT(P<0.05 or P<0.01). Conclusion BMMSC could alleviate GVHD and maintain graft versus leukimia (GVL) after allo-BMT in mice.

关 键 词：GVHD BMT 异基因骨髓移植 生存率 骨髓间充质干细胞 小鼠 CD8^+T细胞 目的观 结论 差异 

分 类 号：R733.7[医药卫生—肿瘤]